List of Tables
Table 1. Global Typhoid Fever Vaccines Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Typhoid Fever Vaccines Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Typhoid Fever Vaccines Market Competitive Situation by Manufacturers in 2024
Table 4. Global Typhoid Fever Vaccines Sales (K Doses) of Key Manufacturers (2020-2025)
Table 5. Global Typhoid Fever Vaccines Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Typhoid Fever Vaccines Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Typhoid Fever Vaccines Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Typhoid Fever Vaccines Average Price (USD/Dose) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Typhoid Fever Vaccines, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Typhoid Fever Vaccines, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Typhoid Fever Vaccines, Product Type & Application
Table 12. Global Key Manufacturers of Typhoid Fever Vaccines, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Typhoid Fever Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Typhoid Fever Vaccines as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Typhoid Fever Vaccines Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Typhoid Fever Vaccines Sales by Region (2020-2025) & (K Doses)
Table 18. Global Typhoid Fever Vaccines Sales Market Share by Region (2020-2025)
Table 19. Global Typhoid Fever Vaccines Sales by Region (2026-2031) & (K Doses)
Table 20. Global Typhoid Fever Vaccines Sales Market Share by Region (2026-2031)
Table 21. Global Typhoid Fever Vaccines Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Typhoid Fever Vaccines Revenue Market Share by Region (2020-2025)
Table 23. Global Typhoid Fever Vaccines Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Typhoid Fever Vaccines Revenue Market Share by Region (2026-2031)
Table 25. North America Typhoid Fever Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Typhoid Fever Vaccines Sales by Country (2020-2025) & (K Doses)
Table 27. North America Typhoid Fever Vaccines Sales by Country (2026-2031) & (K Doses)
Table 28. North America Typhoid Fever Vaccines Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Typhoid Fever Vaccines Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Typhoid Fever Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Typhoid Fever Vaccines Sales by Country (2020-2025) & (K Doses)
Table 32. Europe Typhoid Fever Vaccines Sales by Country (2026-2031) & (K Doses)
Table 33. Europe Typhoid Fever Vaccines Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Typhoid Fever Vaccines Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Typhoid Fever Vaccines Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Typhoid Fever Vaccines Sales by Region (2020-2025) & (K Doses)
Table 37. Asia Pacific Typhoid Fever Vaccines Sales by Region (2026-2031) & (K Doses)
Table 38. Asia Pacific Typhoid Fever Vaccines Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Typhoid Fever Vaccines Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Typhoid Fever Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Typhoid Fever Vaccines Sales by Country (2020-2025) & (K Doses)
Table 42. Latin America Typhoid Fever Vaccines Sales by Country (2026-2031) & (K Doses)
Table 43. Latin America Typhoid Fever Vaccines Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Typhoid Fever Vaccines Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Typhoid Fever Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Typhoid Fever Vaccines Sales by Country (2020-2025) & (K Doses)
Table 47. Middle East and Africa Typhoid Fever Vaccines Sales by Country (2026-2031) & (K Doses)
Table 48. Middle East and Africa Typhoid Fever Vaccines Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Typhoid Fever Vaccines Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Typhoid Fever Vaccines Sales (K Doses) by Type (2020-2025)
Table 51. Global Typhoid Fever Vaccines Sales (K Doses) by Type (2026-2031)
Table 52. Global Typhoid Fever Vaccines Sales Market Share by Type (2020-2025)
Table 53. Global Typhoid Fever Vaccines Sales Market Share by Type (2026-2031)
Table 54. Global Typhoid Fever Vaccines Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Typhoid Fever Vaccines Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Typhoid Fever Vaccines Revenue Market Share by Type (2020-2025)
Table 57. Global Typhoid Fever Vaccines Revenue Market Share by Type (2026-2031)
Table 58. Global Typhoid Fever Vaccines Price (USD/Dose) by Type (2020-2025)
Table 59. Global Typhoid Fever Vaccines Price (USD/Dose) by Type (2026-2031)
Table 60. Global Typhoid Fever Vaccines Sales (K Doses) by Application (2020-2025)
Table 61. Global Typhoid Fever Vaccines Sales (K Doses) by Application (2026-2031)
Table 62. Global Typhoid Fever Vaccines Sales Market Share by Application (2020-2025)
Table 63. Global Typhoid Fever Vaccines Sales Market Share by Application (2026-2031)
Table 64. Global Typhoid Fever Vaccines Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Typhoid Fever Vaccines Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Typhoid Fever Vaccines Revenue Market Share by Application (2020-2025)
Table 67. Global Typhoid Fever Vaccines Revenue Market Share by Application (2026-2031)
Table 68. Global Typhoid Fever Vaccines Price (USD/Dose) by Application (2020-2025)
Table 69. Global Typhoid Fever Vaccines Price (USD/Dose) by Application (2026-2031)
Table 70. Sanofi Pasteur Company Information
Table 71. Sanofi Pasteur Description and Business Overview
Table 72. Sanofi Pasteur Typhoid Fever Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 73. Sanofi Pasteur Typhoid Fever Vaccines Product
Table 74. Sanofi Pasteur Recent Developments/Updates
Table 75. GlaxoSmithKline Company Information
Table 76. GlaxoSmithKline Description and Business Overview
Table 77. GlaxoSmithKline Typhoid Fever Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 78. GlaxoSmithKline Typhoid Fever Vaccines Product
Table 79. GlaxoSmithKline Recent Developments/Updates
Table 80. Bharat Biotech Company Information
Table 81. Bharat Biotech Description and Business Overview
Table 82. Bharat Biotech Typhoid Fever Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 83. Bharat Biotech Typhoid Fever Vaccines Product
Table 84. Bharat Biotech Recent Developments/Updates
Table 85. PaxVax Company Information
Table 86. PaxVax Description and Business Overview
Table 87. PaxVax Typhoid Fever Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 88. PaxVax Typhoid Fever Vaccines Product
Table 89. PaxVax Recent Developments/Updates
Table 90. Biomed Company Information
Table 91. Biomed Description and Business Overview
Table 92. Biomed Typhoid Fever Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 93. Biomed Typhoid Fever Vaccines Product
Table 94. Biomed Recent Developments/Updates
Table 95. Prokarium Company Information
Table 96. Prokarium Description and Business Overview
Table 97. Prokarium Typhoid Fever Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 98. Prokarium Typhoid Fever Vaccines Product
Table 99. Prokarium Recent Developments/Updates
Table 100. China National Biotec Group Company Information
Table 101. China National Biotec Group Description and Business Overview
Table 102. China National Biotec Group Typhoid Fever Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 103. China National Biotec Group Typhoid Fever Vaccines Product
Table 104. China National Biotec Group Recent Developments/Updates
Table 105. Key Raw Materials Lists
Table 106. Raw Materials Key Suppliers Lists
Table 107. Typhoid Fever Vaccines Distributors List
Table 108. Typhoid Fever Vaccines Customers List
Table 109. Typhoid Fever Vaccines Market Trends
Table 110. Typhoid Fever Vaccines Market Drivers
Table 111. Typhoid Fever Vaccines Market Challenges
Table 112. Typhoid Fever Vaccines Market Restraints
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
Table 116. Authors List of This Report
List of Figures
Figure 1. Product Picture of Typhoid Fever Vaccines
Figure 2. Global Typhoid Fever Vaccines Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Typhoid Fever Vaccines Market Share by Type: 2024 & 2031
Figure 4. Live Attenuated Vaccine Product Picture
Figure 5. Conjugate Vaccine Product Picture
Figure 6. Capsular Polysaccharide Vaccines Product Picture
Figure 7. Others Product Picture
Figure 8. Global Typhoid Fever Vaccines Market Value by Application (2020-2031) & (US$ Million)
Figure 9. Global Typhoid Fever Vaccines Market Share by Application: 2024 & 2031
Figure 10. Government Institution
Figure 11. Private Sector
Figure 12. Global Typhoid Fever Vaccines Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Typhoid Fever Vaccines Market Size (2020-2031) & (US$ Million)
Figure 14. Global Typhoid Fever Vaccines Sales (2020-2031) & (K Doses)
Figure 15. Global Typhoid Fever Vaccines Average Price (USD/Dose) & (2020-2031)
Figure 16. Typhoid Fever Vaccines Report Years Considered
Figure 17. Typhoid Fever Vaccines Sales Share by Manufacturers in 2024
Figure 18. Global Typhoid Fever Vaccines Revenue Share by Manufacturers in 2024
Figure 19. Global 5 and 10 Largest Typhoid Fever Vaccines Players: Market Share by Revenue in Typhoid Fever Vaccines in 2024
Figure 20. Typhoid Fever Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 21. Global Typhoid Fever Vaccines Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 22. North America Typhoid Fever Vaccines Sales Market Share by Country (2020-2031)
Figure 23. North America Typhoid Fever Vaccines Revenue Market Share by Country (2020-2031)
Figure 24. U.S. Typhoid Fever Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Canada Typhoid Fever Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 26. Europe Typhoid Fever Vaccines Sales Market Share by Country (2020-2031)
Figure 27. Europe Typhoid Fever Vaccines Revenue Market Share by Country (2020-2031)
Figure 28. Germany Typhoid Fever Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. France Typhoid Fever Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. U.K. Typhoid Fever Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Italy Typhoid Fever Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Russia Typhoid Fever Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Asia Pacific Typhoid Fever Vaccines Sales Market Share by Region (2020-2031)
Figure 34. Asia Pacific Typhoid Fever Vaccines Revenue Market Share by Region (2020-2031)
Figure 35. China Typhoid Fever Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. Japan Typhoid Fever Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. South Korea Typhoid Fever Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. India Typhoid Fever Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Australia Typhoid Fever Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Taiwan Typhoid Fever Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Indonesia Typhoid Fever Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Thailand Typhoid Fever Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Malaysia Typhoid Fever Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Philippines Typhoid Fever Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Latin America Typhoid Fever Vaccines Sales Market Share by Country (2020-2031)
Figure 46. Latin America Typhoid Fever Vaccines Revenue Market Share by Country (2020-2031)
Figure 47. Mexico Typhoid Fever Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Brazil Typhoid Fever Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Argentina Typhoid Fever Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Middle East and Africa Typhoid Fever Vaccines Sales Market Share by Country (2020-2031)
Figure 51. Middle East and Africa Typhoid Fever Vaccines Revenue Market Share by Country (2020-2031)
Figure 52. Turkey Typhoid Fever Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Saudi Arabia Typhoid Fever Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. U.A.E Typhoid Fever Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 55. Global Sales Market Share of Typhoid Fever Vaccines by Type (2020-2031)
Figure 56. Global Revenue Market Share of Typhoid Fever Vaccines by Type (2020-2031)
Figure 57. Global Typhoid Fever Vaccines Price (USD/Dose) by Type (2020-2031)
Figure 58. Global Sales Market Share of Typhoid Fever Vaccines by Application (2020-2031)
Figure 59. Global Revenue Market Share of Typhoid Fever Vaccines by Application (2020-2031)
Figure 60. Global Typhoid Fever Vaccines Price (USD/Dose) by Application (2020-2031)
Figure 61. Typhoid Fever Vaccines Value Chain
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed